Compare Organon Pharma Indonesia Tbk. (SCPI) vs Solusi Tunas Pratama Tbk. (SUPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Solusi Tunas Pratama Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Solusi Tunas Pratama Tbk. trades at Rp43,850 (market cap 49.88T). The key difference: Solusi Tunas Pratama Tbk. is far larger — about 477.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SUPR | |
|---|---|---|
Market Cap | 104.4B | 49.88T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Solusi Tunas Pratama Tbk.
PT Solusi Tunas Pratama Tbk (the company) was established based on the Deed No.5 dated Jul 25, 2006 made in presence of Ridjqi Nurdiani, S.H, a Notary in Bekasi. The Company's articles of association has been amended from time to time, the latest amendment regarding the decrease in nominal value of the Company's shares, the change in the Company's name and the change in the Company's status from private company to public company.
Read more on SUPR →
